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Abstract
Because many species-specific phenotypic differences are assumed to be caused by differential regulation of gene
expression, many recent investigations have focused on measuring transcript abundance. Despite the availability of high-
throughput platforms, quantitative real-time polymerase chain reaction (RT-QPCR) is often the method of choice because of
its low cost and wider dynamic range. However, the accuracy of this technique heavily relies on the use of multiple valid
control genes for normalization. We created a pipeline for choosing genes potentially useful as RT-QPCR control genes for
measuring expression between human and chimpanzee samples across multiple tissues, using published microarrays and a
measure of tissue-specificity. We identified 13 genes from the pipeline and from commonly used control genes: ACTB,
USP49, ARGHGEF2, GSK3A, TBP, SDHA, EIF2B2, GPDH, YWHAZ, HPTR1, RPL13A, HMBS, and EEF2. We then tested these
candidate genes and validated their expression stability across species. We established the rank order of the most preferable
set of genes for single and combined tissues. Our results suggest that for at least three tissues (cerebral cortex, liver, and
skeletal muscle), EIF2B2, EEF2, HMBS, and SDHA are useful genes for normalizing human and chimpanzee expression using
RT-QPCR. Interestingly, other commonly used control genes, including TBP, GAPDH, and, especially ACTB do not perform as
well. This pipeline could be easily adapted to other species for which expression data exist, providing taxonomically
appropriate control genes for comparisons of gene expression among species.
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Introduction
Humans and chimpanzees are about 98.8% similar at the
genomic level of alignable sequences [1]. Despite this modest
genetic divergence, they vary in many remarkable behavioral and
morphological aspects. Chimpanzee-human comparisons not only
provide insights into human origins and contribute to understand-
ing the evolution of uniquely human traits, they also provide
practical medical insights; although there may be pathological and
prognostic differences, the fact remains that chimpanzees and
humans differ in susceptibility and outcomes for many diseases [2].
For instance, Alzheimer’s disease is more common in humans and
progression to AIDS is very rare in chimpanzees infected with
HIV [3]. Humans and chimpanzees are almost identical at the
protein sequence level; hence, it has been hypothesized that most
of the phenotypic differences are caused by the regulation of gene
expression [4]. Many studies have therefore focused on detecting
differences in gene expression between these two species [5–16].
Gene transcript levels can be very precisely and reproducibly
measured with quantitative real-time polymerase chain reaction
(RT-QPCR). This technique is a relatively inexpensive technology
for assaying the expression of a small number of genes. RT-QPCR
is often preferentially used because of its wider dynamic range,
compared to that of microarrays [17], and is used for
corroborating results obtained from deep RNA sequencing [18].
However, the accuracy of RT-QPCR can be confounded by many
sources of variation, including the total RNA content of the
sample, the number of cells in the starting material, the RNA
extraction efficiency, differential enzymatic efficiencies, and
transcriptional activity [19].
One of the most widely used approaches to correct for these
variables is the normalization of expression levels with control
genes [20]. These control genes, also called normalizers or
reference genes, are often chosen from ‘‘housekeeping’’ genes
because they are expected to be evenly expressed across most
tissues and samples. However, caution is required when choosing
control genes. In particular, control genes that are not equally
expressed across samples, especially from different tissues or
species, can affect the accuracy of the calculation of relative
expression differences between samples. Moreover, it has been
shown that using only a single control gene can lead to appreciable
normalization errors and that using several normalizers is
preferable in order to compensate for the potential biases
introduced by an inappropriate normalizer [19,21–22]. Despite
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usually dictated by customary usage rather than empirical
evidence and, most often, only a single control gene is used [23]
(e.g. [7,24]). It seems more and more evident that finding
‘‘universal’’ RT-QPCR control genes is a nearly impossible task.
Instead, it is necessary to identify control genes that are most
appropriate for the species, experimental conditions, and tissue
types being assayed [20–21,25–30].
In order to find control genes for comparing human-
chimpanzee gene expression across multiple tissues, we developed
a pipeline that draws on information from published microarray
datasets for identifying candidate normalizers. These genes were
chosen according to several criteria, including low variance within
and between species and equal expression across tissues. We then
validated each of the candidate control genes and proposed a
minimal set of empirically validated control genes appropriate for
assaying transcript abundance in cerebral cortex, liver, and skeletal
muscle genes.
Results and Discussion
In order to understand the genetic basis of many human specific
traits, it is often relevant to ask whether particular genes are
differentially expressed between humans and their closest living
relative, the chimpanzee [4]. For studies involving a small number
of genes, RT-QPCR is the gold standard for assaying transcript
abundance as it presents several practical advantages [17].
However, this technology requires the use of control genes for
normalization across multiple samples to account for technical and
intrinsic variation [20]. Ideally, these control genes should be
constantly expressed across all assayed samples. In the case of
inter-species comparisons, the selection of these genes is
particularly challenging since they need to be steadily expressed
at multiple levels of comparison: within and between species as
well as across tissues. Because ‘‘universal’’ control genes probably
do not exist, it is important to identify appropriate genes for each
project [20–21,25–30]. In order to find such genes for comparing
human and chimpanzee gene expression across multiple tissues,
we developed a pipeline that consists of three steps: (1) determine a
set of genes from published microarray studies with low variation
between and within species as well as across tissues; (2) design and
test for specificity primers for these genes; and (3) perform
expression assays and variation analyses to determine the best set
of control genes.
Candidate reference genes
We computed the evenness score [31] for 22,667 genes from
the Novartis expression atlas for 27 human tissues and examined
within and between human-chimpanzee variation for 4,365
genes and five tissues. We were able to calculate combined
variation scores (see Materials and Methods) for 3,556 genes
present in both the Novartis expression atlas and the human-
chimpanzee microarray dataset (Table S1). We were interested
in the top 5% of the list (,178 genes) with the smallest score.
Among these promising genes, we selected five genes with non-
related functions and spanning a range of expression levels:
GSK3A, USP49, EEF2, ARHGEF2,a n dEIF2B2 (Table 1). For
comparison, we selected commonly used control genes in the
literature: ACTB, GAPDH, HMBS, HPTR1, RPLI3A, SDHA,
TBP,a n dYWHAZ (Table 1). These genes have been used in
numerous studies; GAPDH and ACTB, in particular, have been
used in previous comparative primate gene expression studies
[7,24]. Interestingly, ACTB, GAPDH,a n dTBP were not among
the 5% most stable genes (Table 2). HMBS, SDHA,a n dRPL13A
were not present in the primate microarray dataset. HMBS and
SDHA were respectively within the 15 and 50% most stably
expressed genes across the 26 Novartis tissues. Due to a lack of
correlation between transcript abundance measurements from
microarray and RT-QPCR technologies, our method does not
guarantee that optimal genes identified in this step of our
pipeline are going to be the most optimal genes for RT-QPCR.
However, we believe that the top 5% of the list of candidates
contains genes with desirable properties for further testing with
the geNorm method.
Table 1. List of candidate genes.
Symbol Name Function Rank
GSK3A Glycogen synthase kinase 3 alpha Involved in hormonal control of regulatory proteins 13*
USP49 Ubiquitin specific peptidase 49 Breakdown peptides 15*
EIF2B2 Eukaryotic translation initiation factor 2B,
subunit 2 beta
Involved in protein synthesis 42*
ARHGEF2 Rho/rac guanine nucleotide exchange
factor (GEF) 2
Activates Rho GTPases, involved in numerous cellular processes
initiated by extracellular stimuli (cell cycle, motility, barrier etc…)
56*
EEF2 Eukaryotic translation elongation factor 2 Essential factor for protein synthesis 162*
ACTB Beta actin Cytoskeletal structural protein 450
TBP TATA box binding protein RNA polymerase II transcription factor 761
GAPDH Glyceraldehyde-3-phosphate dehydrogenase Glycolytic enzyme 990
YWHAZ Tyrosine 3-monooxygenase/trytophan 5-
monooxygenase activation protein, zeta polypeptide
Mediate signal transduction by binding to phosphoserine-containing
proteins
2302
HPRT1 Hypoxanthine phosphoribosyl-transferase 1 Generation of purine nucleotide through the purine salvage pathway 2346
HMBS Hydroxymethylbilane synthase Heme synthesis and porphyrin metabolism ?
SDHA Succinate dehydrogenase complex, subunit A Transfer electrons in the TCA cycle and respiratory chain ?
RPL13A Ribosomal protein L13a Structural constituent of ribosome ?
Genes are ranked according to variation between/within species and evenness across 25 tissues.
*Indicates a gene among the top 5%.
doi:10.1371/journal.pone.0012545.t001
Control Genes for Primates
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We identified a list of genes for further testing, comprising the
five new candidates and four commonly used control genes:
(GSK3A, USP49, EEF2, ARHGEF2, and EIF2B2) and (ACTB,
SDHA, HMBS, and TBP). We used published primer sets for three
of the commonly used genes (ACTB, HMBS, and SDHA) [19], and
we designed new primer sets for the remaining six genes. We
tested these primers and estimated their efficiencies using cDNA
from the IMR32 cell line (Table 2). Interestingly, the published
primer set of ACTB had an efficiency greater than 100% and a
Primer-Blast analysis resulted in multiple hits, the best hit not
being ACTB. We therefore did not include this gene in subsequent
analyses. ‘‘Primer-Blasting’’ SDHA primer sets also lead to multiple
hits. However, the fact that the best hit perfectly mapped onto
SDHA and the fact that the primer efficiency was below 100%, did
not suggest multiple non-specific amplifications. All the other
primer sets had an efficiency ranging from 92.2% to 99.6% and a
unique sequence match to the appropriate gene in both the human
and chimpanzee genomes. We then narrowed our list to eight
genes: GSK3A, USP49, EEF2, ARHGEF2, EIF2B2, SDHA, HMBS,
and TBP. For all eight genes, the threshold cycle values (Ct) vary
between 19.42 and 30.5 (Figure 1). When tissues and species are
combined, HMBS, SDHA, EEF2, and EIF2B2 show the least Ct
variation, while TBP and USP49 show the largest variation.
Expression stability
In order to determine the most stably expressed genes from the
list of eight candidate genes, we used the geNorm method
developed by Vandesompele et al. [19]. We measured expression
levels across three tissues (liver, cerebral cortex, skeletal muscle) for
all eight genes for humans and chimpanzees (two individuals per
species). The eight genes were ranked according to their stability
score M for each tissue and for all tissues combined. Iteratively, the
gene with the highest score (largest variability) was excluded until
we reached the last gene pair (Figure 2; Table 3). Liver and
cerebral cortex tissues exhibited more stability than skeletal muscle
overall, but they converged to the same average stability score
when all genes were included. As expected, there is more variation
in all tissues combined than in each tissue separately, even when
we included all reference genes. Considering tissues taken
individually or combined, including all eight genes seems to be
the optimal strategy. However, there is a tradeoff between
optimality and practicality. In order to determine the minimal
set of genes for which stability would be acceptable and practical,
we calculated and plotted a variation coefficient for including an
additional gene (Figure 3; Table 3). If we consider the tissues
separately (cerebral cortex, skeletal muscle and liver), the best
three normalizers are respectively (Table 3): (EIF2B2, HMBS,
SDHA), (HMBS, EEF2, GSK3A), and (EIF2B2, USP49, TBP).
Adding a fourth gene does not drastically affect the normalization
factor. However, as expected, if we consider all tissues together,
the inclusion of a fourth gene has a large effect on the calculation
of the normalization factor (HMBS, EEF2, EIF2B2, and SDHA). As
practical limitations often preclude the use of too many genes, we
recommend using at least two from this quartet whose Ct range is
close to that of the target genes. The goal of our study is to
determine appropriate genes for multiple species and across
several tissues. The observed discrepancy between individual
tissues and all tissues in table 3 reflects both a bias produced by the
way we selected candidate genes from microarray datasets and the
difficulty of finding ‘‘universal’’ control genes. Finding optimal
control genes for multiple tissues does not guarantee that they are
the best for individual tissues. If one wants to focus on a single
tissue, it is preferable to determine a new set of candidate genes for
this tissue alone.
Conclusion
In addition to proposing, for the first time, a set of adequate
reference genes for comparing human and chimpanzee gene
expression, our study also proposes a pipeline that can be easily
Table 2. Primer sequences for candidate control genes, efficiency, and primerBlast results.
Symbol Forward primer Reverse Primer Eff% PrimerBlast Hit(s) Chr#
GSK3A CCCAACTACACGGAGTTCAA CCAGCAGGCTAGAGCAGAG 92.2 GSK3A 19*
USP49 CTCAGCCACCTCCAGAAGTT AAAGCTGAGTCTTCCCGTTG 95.8 USP49 6*
EIF2B2 TCAAGATTATCCGGGAGGAG ATGGAAGCTGAAATCCTCGT 96.5 EIF2B2 14*
ARHGEF2 ATCTACCCCTCCGACAGCTT CCAGGGGAGACTCATCATTG 95 ARHGEF2 1*
EEF2 AGAAGCTGTGGGGTGACAG GATCAGCTGGCAGAAGGTG 96.2 EEF2 19*
ACTB CTGGAACGGTGAAGGTGACA AAGGGACTTCCTGTAACAATGCA 109.4 LOC644936 (Beta-actin
pseudogene)
5*
ACTB 7
A26C1B 2
LOC653269 2
TBP GCTGAGAAGAGTGTGCTGGA GTAAGGTGGCAGGCTGTTGT 95.8 TBP 6*
HMBS GGCAATGCGGCTGCAA GGGTACCCACGCGAATCAC 99.2 HMBS transcript variant 1 11*
SDHA TGGGAACAAGAGGGCATCTG CCACCACTGCATCAAATTCATG 99.6 SDHA 5*
SDHALP1 3
SDHALP2 3
LOC220729 (SDHA
pseudogene)
3
LOC100134106 3
*Indicates that both the forward and reverse primers are perfect matches.
doi:10.1371/journal.pone.0012545.t002
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Many control gene lists have been previously published [28,32–35]
but they are limited to their own specific application. In addition,
our approach is not based entirely on an a priori candidate gene list
but also includes genes based on comparative studies across
multiple species and tissues using a novel calculation of tissue
expression evenness [31]. While other studies have proposed
methods to detect candidate control genes based on microarray
data [23,34–35], to our knowledge, our pipeline is the first attempt
to implement an approach appropriate for comparisons among
species.
Materials and Methods
Gene selection
An appropriate control gene for comparing human and
chimpanzee expression across multiple tissues was defined by
steady expression between and within species as well as across
tissues. We established a genome-wide list of candidate normal-
izers by comparing their level of expression from published
microarray studies. Specifically, we used human microarray data
from the Novartis Gene Expression Atlas (http://biogps.gnf.org/)
and several microarrays from a human-chimpanzee study [14].
First, the Novartis expression dataset was analyzed to assess
human gene expression evenness across tissues. We examined
22,667 genes in 26 selected non-cancerous tissues: central nervous
system (temporal lobe, globus pallidus, cerebellum peduncles,
cerebellum, caudate nucleus, whole brain, parietal lobe, medulla
oblongata, amygdala, prefrontal cortex, occipital lobe, thalamus,
subthalamic nucleus, cingulate cortex, pons, fetal brain, olfactory
bulb), skeletal muscle, kidney, liver, heart, and testis (testis, testis
leydig cell, testis germ cell, testis interstitial, testis seminiferous
tubule). We determined the evenness of expression across these
tissues for each gene based on a previously published approach
Figure 1. Variation of threshold cycle levels. Box plot of threshold cycle levels of candidate genes for human-chimpanzee samples across
combined tissues: skeletal muscle, liver, and cerebral cortex.
doi:10.1371/journal.pone.0012545.g001
Figure 2. Average expression stability with iterative exclusion of the least stable gene. Low average M values indicate high stability and
high average M values indicate less stability.
doi:10.1371/journal.pone.0012545.g002
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dimensional space representing its expression in every tissue (i.e.
each tissue is represented by an axis). We used a geometric
calculation to determine the evenness of expression across all
tissues. If a gene were perfectly evenly expressed, its vector would
form equal angles with each axis – we defined this as the expected
expression vector. The evenness score e of a gene is calculated
as the squared cosine of the angle e between the actual ex-
pression vector and the expected expression vector: e~cos2 e~
P n
i~1
expri
   2,
n|
P n
i~1
expri ðÞ
2 where n is the total number of
assayed tissues and expri is the gene expression for tissue i. If this
gene is equally expressed across all tissues, e=1, while, if it is only
expressed in a single tissue, e will be small (0.04 in the case of 25
tissues). We then ranked all genes according to their expression
evenness.
Secondly, we used the human-chimpanzee microarray dataset
(11,780 genes) [14] to determine whether a gene has constant
expression within and between species. For the genes for which
both within and between species variation has been assayed as the
mean squared difference (4,365 genes), we calculated and
normalized the average and standard deviation within and
between species for all five tissues (brain, heart, testis, kidney, and
liver) [14]. The goal of this step was to identify genes that have
small differences between and within species across the five
tissues. We sorted the list of genes according to the product of
these values (score of differences). Finally, we intersected the gene
lists established from the evenness calculation and from the
human-chimpanzee microarrays and calculated a combined
variation score (product of 1-evenness and score of differences).
We then ranked them from the most steady (low score) to the
least steady (high score). Although outliers may influence it, this
metric is sufficient for establishing a list of candidates for further
scrutiny (i.e. geNorm analysis). We chose a final set of candidate
genes from among the high scoring genes (top 5%) according to
three additional criteria: (1) genes that cover a wide range of
Figure 3. Optimal number of control genes. The optimal number of control genes was determined by pairwise variations (Vn/n+1) between the
normalization factors NFn and NFn+1. The black arrows indicate the optimal number of genes to use for RT-QPCR normalization. For each tissue, the
inclusion of a fourth gene does not significantly change the normalization factor. For all tissues combined, the use of a fourth gene has a large effect
on the normalization factor.
doi:10.1371/journal.pone.0012545.g003
Table 3. Ranking of candidate control genes after geNorm
analyses for individual and combined tissues.
All tissues Cortex Muscle Liver
EIF2B2-EEF2 EIF2B2-HMBS EEF2-GSK3A EIF2B2-USP49
HMBS SDHA HMBS TBP
SDHA GSK3A ARHGEF2 HMBS
TBP EEF2 EIF2B2 GSK3A
GSK3A TBP TBP SDHA
ARHGEF2 ARHGEF2 SDHA EEF2
USP49 USP49 USP49 ARHGEF2
The best pair of genes is listed first.
doi:10.1371/journal.pone.0012545.t003
Control Genes for Primates
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not mainly influenced by one extreme value; (2) genes with a
‘‘housekeeping’’ function which may be more likely to be valid
control genes; and (3) genes that are unlikely to be co-regulated.
For comparison, we also included a few commonly used control
genes.
RT-QPCR
Human total RNA samples were obtained from Biochain
(http://www.biochain.com/) and chimpanzee tissue samples from
the Southwest Foundation for Biomedical Research for cerebral
cortex (humans: A803159, A803148; chimpanzees: 4X0505,
4X0391), liver (humans: A602084, A507018; chimpanzees:
4X0505, 4X0391), and skeletal muscle (humans: A811244,
A508352; chimpanzees: 4X0505, 4X0391). Different RNA
extraction kits and protocols were used for processing different
tissues: QIAGEN RNeasyH Lipid Tissue Kit for cerebral cortex
samples, QIAGEN RNeasyH Kit for liver samples, and QIAGEN
RNeasyH Fibrous Tissue Kit for skeletal muscle samples. 6mgo f
total RNA were reverse transcribed into cDNA according to the
manufacturer’s protocol using a High Capacity cDNA Reverse
Transcription Kit Archive Kit (P/N 4368813) from Applied
BiosystemsH. For all candidate genes, primers were designed in
conserved exonic regions across species and transcript isoforms.
Sequences of these regions were then mapped to the human and
chimpanzee genomes to verify their uniqueness using Primer-Blast
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Primers were
designed using Primer3 [36] with the following parameters: 100–
150 base pairs (bp) product long, primer Tm min 58uC, opt 59uC,
max 61uC; primer size min 17 bp, opt 20 bp; max 23 bp. We
performed standard curves on each set of primers using cDNA
from an IMR32 cell line with a dilution series (eight dilutions). The
R
2 of this dilution series and primer set efficiency were calculated.
The efficiency was determined as follows: Eff~
10{1=slope
2
|100
where slope is the regression line slope. Expression levels were
measured on the ABI PRISM 7000. 30 ml reactions contained
15 ml2 6 ABGene Absolute q-PCR SYBRH Green Mix, 0.75 ml
for each primer (10 mM), 1 ml of cDNA template, and PCR quality
water to reach the desired volume. The RT-QPCR program was:
95uC for 15 minutes, 40 cycles of a 15 second melt at 95uC, and a
30 second annealing/elongation at 60uC. The program ended
with a dissociation curve from 50 to 90uC. Reactions were done in
technical triplicates and those with a standard deviation above 0.3
were excluded and rerun.
Data analysis
We used the geNorm algorithm [19] implemented in the R
package SLRT-QPCR (http://www.bioconductor.org/packages/
2.2/bioc/html/SLRT-QPCR.html) and customized python scripts
to determine the best set of control genes among all the candidates.
The expression ratio of two ideal control genes should be similar
across all samples, therefore the variation of these ratios should be
small. To quantify the performance of a gene as an appropriate
control gene, we used a gene-stability score M, that is the average
pairwise variation of this gene with all the other genes. First, we
calculated the relative quantity of each gene g and sample i with the
delta-Ct formula [37]. Second, we assigned a stability rank to each
gene using an iterative process: starting from the complete set of
candidate control genes, we computed the stability measurement M
for each gene and iteratively excluded the least stable (the gene with
the lowest M is the most stable while the gene with the highest M is
the least stable). Finally, we used this ranked list to determine the
optimal set of genes for RT-QPCR normalization by calculating the
effect of including one additional gene to the set [19]. We calculated
a normalization factor NF (geometric mean of expression values) for
subsets n and n+1; a large pairwise variation (Vn/n+1) between NFn
and NFn+1 values indicates a non-negligible improvement for the
inclusion of an additional gene.
Supporting Information
Table S1 Complete results from the candidate control genes
selection pipeline.
Found at: doi:10.1371/journal.pone.0012545.s001 (0.94 MB
XLS)
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